semaglutide getting banned Ozempic Knock-Offs Contain Unsafe Substance by FDA, Novo Finds Regulator acts to close loophole

Kraus D, et al

It is not medical advice, dosing guidance, or a recommendation for human use

Safety data over the 16-week treatment period showed: Overall rates of adverse events (AEs) were 65% for Dupixent every four weeks, 61% for Dupixent every two weeks, and 72% and 75% for TCS alone, respectively

We also provide ongoing support for individuals taking GLP-1 based medications through our Check-In and Optimization sessions

Semaglutide temporarily reduces appetite, but stopping the medication typically restores hunger signals within weeks

If you develop lymphadenopathy whilst taking Ozempic, seek medical evaluation to identify the underlying cause